HA
CELG

Halsey Associates’s Celgene Corp CELG Stock Holding History

Halsey Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$5.21M Sell
52,459
-161
-0.3% -$15.3K 0.83% 36
2019
Q2 		$4.86M Sell
52,620
-92,391
-64% -$8.77M 0.87% 35
2019
Q1 		$13.7M Sell
145,011
-1,809
-1% -$158K 2.25% 18
2018
Q4 		$9.41M Sell
146,820
-3,059
-2% -$226K 1.77% 23
2018
Q3 		$13.4M Buy
149,879
+202
+0.1% +$17.9K 2.38% 16
2018
Q2 		$11.9M Sell
149,677
-6,868
-4% -$570K 2.31% 16
2018
Q1 		$14M Buy
156,545
+1,146
+0.7% +$110K 2.46% 15
2017
Q4 		$16.2M Buy
155,399
+7,988
+5% +$901K 2.77% 13
2017
Q3 		$21.5M Sell
147,411
-3,721
-2% -$507K 4.24% 3
2017
Q2 		$19.6M Sell
151,132
-176
-0.1% -$21.6K 4.03% 3
2017
Q1 		$18.8M Buy
151,308
+460
+0.3% +$55K 3.99% 3
2016
Q4 		$17.5M Sell
150,848
-2,603
-2% -$290K 3.89% 4
2016
Q3 		$16M Sell
153,451
-829
-0.5% -$89.7K 3.48% 4
2016
Q2 		$15.2M Buy
154,280
+3,856
+3% +$399K 3.39% 6
2016
Q1 		$15.1M Buy
150,424
+1,490
+1% +$153K 3.38% 6
2015
Q4 		$17.8M Sell
148,934
-295
-0.2% -$34.1K 4.12% 4
2015
Q3 		$16.1M Sell
149,229
-3,593
-2% -$446K 3.79% 5
2015
Q2 		$17.7M Sell
152,822
-1,996
-1% -$228K 3.95% 4
2015
Q1 		$17.8M Sell
154,818
-15,369
-9% -$1.84M 3.89% 5
2014
Q4 		$19M Sell
170,187
-6,835
-4% -$721K 4.19% 3
2014
Q3 		$16.8M Sell
177,022
-19,374
-10% -$1.75M 3.77% 4
2014
Q2 		$16.9M Sell
196,396
-2,980
-1% -$227K 3.71% 5
2014
Q1 		$13.9M Buy
199,376
+9,226
+5% +$731K 3.16% 9
2013
Q4 		$16.1M Sell
190,150
-27,916
-13% -$2.21M 3.66% 6
2013
Q3 		$16.8M Sell
218,066
-5,770
-3% -$404K 4.08% 3
2013
Q2 		$13.1M Buy
+223,836
New +$13.5M 3.36% 8

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Halsey Associates's CELG Position: Q3 2019 in Review

Halsey Associates reduced its Celgene Corp (CELG) stake by 0.31% in Q3 2019, selling an estimated $15.3K and leaving 52,459 shares worth $5.21M. The position accounts for 0.83% of the portfolio, ranked #36.

Halsey Associates first reported a position in CELG in Q2 2013 and has held it in 26 quarters since. The position peaked at $21.5M in Q3 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Halsey Associates held 52,459 shares of Celgene Corp worth $5.21M as of Q3 2019.
  • Halsey Associates sold 161 Celgene Corp shares in Q3 2019, an estimated $15.3K.
  • Celgene Corp made up 0.83% of Halsey Associates's portfolio in Q3 2019, its #36 holding.
  • Halsey Associates first reported a position in Celgene Corp in Q2 2013 and has held it in 26 quarters since.
  • Halsey Associates's Celgene Corp position peaked at $21.5M in Q3 2017.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Halsey Associates's 13F filing for Q3 2019, filed 15 Nov 2019.